157 related articles for article (PubMed ID: 9009120)
1. Possible mechanism of increase in gastric mucosal PGE2 and PGI2 generation induced by ecabet sodium, a novel gastroprotective agent.
Kinoshita M; Tamaki H
Dig Dis Sci; 1997 Jan; 42(1):83-90. PubMed ID: 9009120
[TBL] [Abstract][Full Text] [Related]
2. Effects of ecabet sodium (TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats.
Kinoshita M; Iwasaki H; Yasoshima A; Tamaki H
Biol Pharm Bull; 1993 Dec; 16(12):1220-5. PubMed ID: 8130770
[TBL] [Abstract][Full Text] [Related]
3. Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats.
Kinoshita M; Noto T; Tamaki H
Biol Pharm Bull; 1995 Feb; 18(2):223-6. PubMed ID: 7742788
[TBL] [Abstract][Full Text] [Related]
4. Effects of ecabet sodium, a novel gastroprotective agent, on mucin metabolism in rat gastric mucosa.
Ichikawa T; Ishihara K; Hayashida H; Hiruma H; Saigenji K; Hotta K
Dig Dis Sci; 2000 Mar; 45(3):606-13. PubMed ID: 10749340
[TBL] [Abstract][Full Text] [Related]
5. Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium.
Kinoshita M; Kume E; Tamaki H
J Pharmacol Exp Ther; 1995 Oct; 275(1):494-501. PubMed ID: 7562591
[TBL] [Abstract][Full Text] [Related]
6. Activation of arachidonoyl phospholipase A2 in prostaglandin-mediated action of sucralfate.
Slomiany BL; Murty VL; Piotrowski E; Morita M; Piotrowski J; Slomiany A
Gen Pharmacol; 1994 Mar; 25(2):261-6. PubMed ID: 8026724
[TBL] [Abstract][Full Text] [Related]
7. Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats. Comparison with sucralfate.
Kinoshita M; Yamasaki K; Kokusenya Y; Tamaki H
Dig Dis Sci; 1995 Mar; 40(3):661-7. PubMed ID: 7895562
[TBL] [Abstract][Full Text] [Related]
8. Effect of ecabet disodium, a novel locally-acting antiulcer drug, on epithelial restitution following injury by hypertonic NaCl in bullfrog stomach in vitro.
Furukawa O; Kume E; Sugamoto S; Kawauchi S; Takeuchi K
Digestion; 2000; 62(2-3):116-25. PubMed ID: 11025359
[TBL] [Abstract][Full Text] [Related]
9. Effects of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric mucosal lesions induced by necrotizing agents and gastric mucosal defensive factors in rats.
Onoda Y; Takido M; Magaribuchi T; Tamaki H
Jpn J Pharmacol; 1990 Apr; 52(4):631-8. PubMed ID: 2342230
[TBL] [Abstract][Full Text] [Related]
10. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat.
Kinoshita M; Endo M; Yasoshima A; Saito N; Yamasaki K; Chishima S; Narita H
Aliment Pharmacol Ther; 1999 May; 13(5):687-94. PubMed ID: 10233194
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin production in cultured gastric mucosal cells: role of cAMP on its modulation.
Hiraishi H; Terano A; Ota S; Shiga J; Kobayashi T; Harada H; Ishii M; Ivey J; Sugimoto T
Prostaglandins; 1986 Aug; 32(2):259-73. PubMed ID: 3025933
[TBL] [Abstract][Full Text] [Related]
12. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. I. Inactivation of enzyme protein.
Ito Y; Nakamura S; Onoda Y; Sugawara Y; Takaiti O
Jpn J Pharmacol; 1993 Jun; 62(2):169-74. PubMed ID: 8371515
[TBL] [Abstract][Full Text] [Related]
13. Effects of the anti-ulcer agents ecabet sodium, cimetidine and sucralfate on acetylsalicylic acid-induced gastric mucosal damage deteriorated by renal failure in rats.
Nogi K; Taniguchi H; Onoda Y
Arzneimittelforschung; 2002; 52(11):828-32. PubMed ID: 12489254
[TBL] [Abstract][Full Text] [Related]
14. Effect of omeprazole on eicosanoid formation in and release from guinea-pig gastric mucosal cells.
Hell M; Sewing KF
Br J Pharmacol; 1987 May; 91(1):69-75. PubMed ID: 3297228
[TBL] [Abstract][Full Text] [Related]
15. Effect of a new anti-ulcer drug, (3-[p-(trans-4-aminomethylcyclohexylcarbonyl)-phenyl] propionic acid hydrochloride, TEI-5103) on prostaglandin (PG) levels in rat gastric mucosa.
Yamazaki N; Hoshina K; Takahama S; Suwa Y; Takeshita T; Naruchi T
Gen Pharmacol; 1988; 19(4):547-51. PubMed ID: 3165898
[TBL] [Abstract][Full Text] [Related]
16. Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells.
Kusumoto K; Kawahara T; Kuwano Y; Teshima-Kondo S; Morita K; Kishi K; Rokutan K
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G300-7. PubMed ID: 15458921
[TBL] [Abstract][Full Text] [Related]
17. Effects of the new anti-ulcer drug ecabet sodium (TA-2711) on pepsin activity. II. Interaction with substrate protein.
Ito Y; Onoda Y; Nakamura S; Tagawa K; Fukushima T; Sugawara Y; Takaiti O
Jpn J Pharmacol; 1993 Jun; 62(2):175-81. PubMed ID: 8371516
[TBL] [Abstract][Full Text] [Related]
18. Activation of PGE2-secretion from gastric mucosa by a type I phospholipase C is mediated by a direct release of arachidonic acid.
Preclik G; Stange EF; Ditschuneit H
Clin Physiol Biochem; 1992; 9(2):78-86. PubMed ID: 1304434
[TBL] [Abstract][Full Text] [Related]
19. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus.
Pearson JP; Roberts NB
Clin Sci (Lond); 2001 Apr; 100(4):411-7. PubMed ID: 11256980
[TBL] [Abstract][Full Text] [Related]
20. Follicle-stimulating hormone-induced phospholipase A2 activity and eicosanoid generation in rat Sertoli cells.
Jannini EA; Ulisse S; Cecconi S; Cironi L; Colonna R; D'Armiento M; Santoni A; Cifone MG
Biol Reprod; 1994 Jul; 51(1):140-5. PubMed ID: 7918869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
